Literature DB >> 22525720

Current challenges in the diagnosis and management of fever.

Joshua M Sherman1, Sunil K Sood.   

Abstract

PURPOSE OF REVIEW: We review recommendations from recent publications on the management of fever with antipyretics, the classification and diagnosis of fevers of unknown origin (FUO), and the evaluation of fever in infants under 90 days of age. RECENT
FINDINGS: Anxiety about fever persists in the population, while the toxicity of antipyretics is an increasing concern. The numerous opportunities for overdosing with antipyretics have been emphasized by the American Academy of Pediatrics (AAP). The practice of alternating acetaminophen and ibuprofen has limited value. Nonclassic FUO and pseudo-FUO are as important to consider as true FUO, and clinicians should become familiar with the variety of periodic fever syndromes. The clinical utility of low-risk criteria to identify febrile infants at low risk for serious bacterial infection (SBI) was demonstrated in a systematic review of studies.
SUMMARY: Pediatricians should spend more time educating parents about fever and antipyretic use. Not all persistent fever is FUO, and testing should be targeted to the child's clinical condition. Existing low-risk criteria should be used to identify febrile infants who can be managed without extensive work-up and antibiotics. Adherence to evidence-based recommendations will lessen the morbidity and mortality associated with febrile illnesses in children.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22525720     DOI: 10.1097/MOP.0b013e32835333e3

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  8 in total

Review 1.  [Fever of unknown origin].

Authors:  B Salzberger; M Müller-Schilling; M Fleck
Journal:  Z Rheumatol       Date:  2013-04       Impact factor: 1.372

2.  Homeopathic medications as clinical alternatives for symptomatic care of acute otitis media and upper respiratory infections in children.

Authors:  Iris R Bell; Nancy N Boyer
Journal:  Glob Adv Health Med       Date:  2013-01

3.  Prescription patterns of analgesics, antipyretics, and non steroidal anti-inflammatory drugs for the management of fever and pain in pediatric patients: a cross-sectional, multicenter study in Latin America, Africa, and the Middle East.

Authors:  María Carolina Kamel Escalante; Abbas Abdennour; Antoine Farah; Ernesto Rivera-Richardson; Fernando Burgos; Ilenia Forero; Margarita Murrieta-Aguttes; Mohamed El Laboudy; Ndeye Ramatoulaye Diagne-Gueye; Sergio Barragan Padilla
Journal:  Pragmat Obs Res       Date:  2019-08-15

4.  Parental Approach to the Management of Childhood Fever: Differences between Health Professional and Non-Health Professional Parents.

Authors:  María Gloria Villarejo-Rodríguez; Beatriz Rodríguez-Martín
Journal:  Int J Environ Res Public Health       Date:  2019-10-20       Impact factor: 3.390

5.  A Cross-Sectional Study on Subjective Fever Assessment in Children by Palpation: Are Fathers as Reliable as Mothers?

Authors:  Ehud Rosenbloom; Crysta Balis; Dustin Jacobson; Melanie Conway; Ji Cheng; Eran Kozer
Journal:  Emerg Med Int       Date:  2020-02-12       Impact factor: 1.112

Review 6.  Analysis of Nurses' and Physicians' Attitudes, Knowledge, and Perceptions toward Fever in Children: A Systematic Review with Meta-Analysis.

Authors:  Francisco Vicens-Blanes; Rosa Miró-Bonet; Jesús Molina-Mula
Journal:  Int J Environ Res Public Health       Date:  2021-11-26       Impact factor: 3.390

7.  Pediatric hemophagocytic lymphohistiocytosis: A rarely diagnosed entity in a developing country.

Authors:  Daniela Cleves; Viviana Lotero; Diego Medina; Paola M Perez; Jaime A Patiño; Laura Torres-Canchala; Manuela Olaya
Journal:  BMC Pediatr       Date:  2021-09-18       Impact factor: 2.125

8.  Human herpes viruses are associated with classic fever of unknown origin (FUO) in Beijing patients.

Authors:  Weimin Zhou; Xinyi Tan; Yamin Li; Wenjie Tan
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.